The live program has concluded.
If you attended, please click on the "Take Post-Test" button to claim your credit. If you did not attend, please stay tuned for the archived version, which will be available soon for on-demand viewing.
These courses will focus on the pathophysiology, assessment, diagnosis, and treatment of psoriasis, atopic dermatitis (AD), hidradenitis supparativa (HS), and psoriatic arthritis (PsA). Immunology as well as existing and emerging therapies will be presented through lectures, panel discussions by thought leaders, and audience engagement.
Supported by unrestricted educational grants from Bristol Myers Squibb, and Leo Pharma.
Upon completion of this activity, the participant should be able to:
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Evolve Medical Education, LLC and the Dermatology Education Foundation. Evolve Medical Education, LLC is accredited by the ACCME to provide continuing medical education for physicians.
Designation Statement Evolve Medical Education, LLC designates this live activity for a maximum of 4 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
PA CONTINUING EDUCATION PAs may claim a maximum of 4 Category 1 credits for completing this activity. National Commission on Certification of Physician Assistants (NCCPA) accepts AMA PRA Category 1 CreditsTM from organizations accredited by ACCME or a recognized state medical society.
NURSE PRACTITIONER CONTINUING EDUCATION The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts certificates of participation for educational activities certified for AMA PRA Category 1 CreditsTM from organizations accredited by the ACCME. Individuals are responsible for checking with the AANPCP for further guidelines.
This activity is designated for 2.25 pharmacology credits.
Joseph Gorelick, MSN, FNP-C
Founder, Dermatology Education Foundation
California Skin Institute
San Jose-Los Gatos, CA
April Armstrong, MD, MPH
Professor of Dermatology
University of Southern California
Los Angeles, California
Kara S. Gooding, MMS, PA-C
Center for Dermatology and Plastic Surgery
Scottsdale, AZ
David E. Cohen, MD, MPH
Charles and Dorothea Harris Professor
and Executive Vice Chairman for Operations and Strategy
Director of Allergic, Occupational and Environmental Dermatology
New York University School of Medicine Department of Dermatology
Joseph Gorelick, MSN, FNP-C
Founder, Dermatology Education Foundation
California Skin Institute
San Jose-Los Gatos, CA
April Armstrong, MD, MPH
Professor of Dermatology
University of Southern California
Los Angeles, California
Kara S. Gooding, MMS, PA-C
Center for Dermatology and Plastic Surgery
Scottsdale, AZ
David E. Cohen, MD, MPH
Charles and Dorothea Harris Professor
and Executive Vice Chairman for Operations and Strategy
Director of Allergic, Occupational and Environmental Dermatology
New York University School of Medicine Department of Dermatology
DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.
The following faculty/staff members have the following financial relationships with ineligible companies.
Joseph Gorelick, MSN, FNP-C, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: BMS and Novartis. Speaker’s Bureau: AbbVie, Eli Lilly, Incyte, Janssen, Leo Pharma, and Pfizer.
April Armstrong, MD, MPH, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: AbbVie, Almirall, Arcutis, Aslan, Beiersdorf, Boehringer Ingelheim, BMS, Dermavant, Dermira, EPI, Incyte, Janssen, Leo, Lilly, ModMed, Nimbus, Novartis, Ortho Dermatologics, Pfizer, Regeneron, Sanofi, Sun and UCB.
Kara S. Gooding, MMS, PA-C, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Incyte and Pfizer. Speaker’s Bureau: Amgen, Almirall, EpiHealth, Galderma, Incyte, Leo, Pfizer and Sun Pharma.
David E. Cohen, MD, MPH, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Cosmetic Ingredient Review, Ferndale, FIDE, FSJ, and Novartis. Board of Directors: Evommune, Kadmon, and Timber.
Erin Fletcher of Evolve Medical Education LLC have no real or apparent conflicts of interest to report.
Stacey Moore of Physician Resources, LLC has no real or apparent conflicts of interest to report.
OFF-LABEL STATEMENT This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve Medical Education, Dermatology Education Foundation, Physician Resources, Bristol Myers Squibb, or Leo Pharma.
Expiration Date:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!